Nothing Special   »   [go: up one dir, main page]

AUPN089295A0 - Treatment of diabetic neuropathy - Google Patents

Treatment of diabetic neuropathy

Info

Publication number
AUPN089295A0
AUPN089295A0 AUPN0892A AUPN089295A AUPN089295A0 AU PN089295 A0 AUPN089295 A0 AU PN089295A0 AU PN0892 A AUPN0892 A AU PN0892A AU PN089295 A AUPN089295 A AU PN089295A AU PN089295 A0 AUPN089295 A0 AU PN089295A0
Authority
AU
Australia
Prior art keywords
treatment
diabetic neuropathy
neuropathy
diabetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPN0892A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
International Diabetes Institute
Original Assignee
International Diabetes Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Diabetes Institute filed Critical International Diabetes Institute
Priority to AUPN0892A priority Critical patent/AUPN089295A0/en
Publication of AUPN089295A0 publication Critical patent/AUPN089295A0/en
Priority to CA002211450A priority patent/CA2211450A1/en
Priority to PCT/AU1996/000046 priority patent/WO1996023522A1/en
Priority to AU45315/96A priority patent/AU4531596A/en
Priority to KR1019970705293A priority patent/KR19980701896A/en
Priority to JP8523119A priority patent/JPH11502513A/en
Priority to EP96901190A priority patent/EP0808170A1/en
Priority to MXPA/A/1997/005920A priority patent/MXPA97005920A/en
Priority to NO973548A priority patent/NO973548L/en
Priority to FI973216A priority patent/FI973216A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AUPN0892A 1995-02-02 1995-02-02 Treatment of diabetic neuropathy Abandoned AUPN089295A0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AUPN0892A AUPN089295A0 (en) 1995-02-02 1995-02-02 Treatment of diabetic neuropathy
EP96901190A EP0808170A1 (en) 1995-02-02 1996-02-01 Treatment of diabetic neuropathy
KR1019970705293A KR19980701896A (en) 1995-02-02 1996-02-01 Treatment of diabetic neuropathy
PCT/AU1996/000046 WO1996023522A1 (en) 1995-02-02 1996-02-01 Treatment of diabetic neuropathy
AU45315/96A AU4531596A (en) 1995-02-02 1996-02-01 Treatment of diabetic neuropathy
CA002211450A CA2211450A1 (en) 1995-02-02 1996-02-01 Treatment of diabetic neuropathy
JP8523119A JPH11502513A (en) 1995-02-02 1996-02-01 Methods for treating diabetic neuropathy
MXPA/A/1997/005920A MXPA97005920A (en) 1995-02-02 1997-08-01 Treatment of neuropathy diabet
NO973548A NO973548L (en) 1995-02-02 1997-08-01 Treatment of diabetic neuropathy
FI973216A FI973216A (en) 1995-02-02 1997-08-04 Treatment of diabetic neuropathy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPN0892A AUPN089295A0 (en) 1995-02-02 1995-02-02 Treatment of diabetic neuropathy

Publications (1)

Publication Number Publication Date
AUPN089295A0 true AUPN089295A0 (en) 1995-03-02

Family

ID=3785252

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPN0892A Abandoned AUPN089295A0 (en) 1995-02-02 1995-02-02 Treatment of diabetic neuropathy

Country Status (8)

Country Link
EP (1) EP0808170A1 (en)
JP (1) JPH11502513A (en)
KR (1) KR19980701896A (en)
AU (1) AUPN089295A0 (en)
CA (1) CA2211450A1 (en)
FI (1) FI973216A (en)
NO (1) NO973548L (en)
WO (1) WO1996023522A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU223205B1 (en) 1996-12-03 2004-03-29 Zoltán Dárdai Topical pharmaceutical composition for applicating peptidelike compounds into the living organismus
IL154210A0 (en) * 2000-07-31 2003-07-31 Univ Bar Ilan Methods and pharmaceutical compositions for healing wounds
US20040037828A1 (en) 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
JP4668902B2 (en) 2003-08-07 2011-04-13 ヒーラー リミテッド Pharmaceutical composition and method for promoting wound healing
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
JP5670421B2 (en) 2009-03-31 2015-02-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Component surface coating method
JP5763053B2 (en) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Adapter, inhaler and atomizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
UA107097C2 (en) 2009-11-25 2014-11-25 Бьорінгер Інгельхайм Інтернаціональ Гмбх Dispenser
JP5658268B2 (en) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
US20140194353A1 (en) * 2010-11-30 2014-07-10 Joslin Diabetes Center, Inc. Compositions and methods for the treatment of nervous disorders associated with diabetes
EP2694220B1 (en) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medical device comprising a container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (en) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Atomiser with coding means
US9744313B2 (en) 2013-08-09 2017-08-29 Boehringer Ingelheim International Gmbh Nebulizer
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
WO2015169732A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Container, nebulizer and use
EP3139984B1 (en) 2014-05-07 2021-04-28 Boehringer Ingelheim International GmbH Nebulizer
RS63171B1 (en) 2014-05-07 2022-05-31 Boehringer Ingelheim Int Nebulizer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4136685A (en) * 1984-04-18 1985-10-24 Geriaco A.G. Product for the treatment of acne vulgaris
AU4292585A (en) * 1984-04-30 1985-11-28 Trustees Of Columbia University In The City Of New York, The Topical treatment of diabetes with insulin and penetrant enhancer applied to the skin and covered by a patch
DD254881A1 (en) * 1986-10-29 1988-03-16 Univ Dresden Tech NON-PARENTERAL APPLICABLE INSULIN PREPARATION WITH DELAYED EFFECT
US5145679A (en) * 1989-10-05 1992-09-08 Hinson Joan B Topical emollient for prevention and treatment of circulatory induced lesions
JPH04149126A (en) * 1990-10-09 1992-05-22 Mitsubishi Kasei Corp Pharmaceutical composition for transmucous administration
DE4208552A1 (en) * 1992-03-17 1993-09-23 Liedtke Pharmed Gmbh TOPICAL MEDICINE FORMS WITH INSULIN
FR2710530B1 (en) * 1993-09-29 1995-12-22 Phedon Zirinis Aqueous gel for nasal use, pellets, and their preparation process.
FR2710529A1 (en) * 1993-09-29 1995-04-07 Zirinis Phedon Aqueous gel for nasal use, pellets, and process for preparing them

Also Published As

Publication number Publication date
FI973216A0 (en) 1997-08-04
NO973548L (en) 1997-10-02
KR19980701896A (en) 1998-06-25
EP0808170A1 (en) 1997-11-26
NO973548D0 (en) 1997-08-01
WO1996023522A1 (en) 1996-08-08
CA2211450A1 (en) 1996-08-08
FI973216A (en) 1997-10-01
JPH11502513A (en) 1999-03-02
MX9705920A (en) 1998-06-28

Similar Documents

Publication Publication Date Title
AU6513096A (en) Treatment of fabrics
AUPN089295A0 (en) Treatment of diabetic neuropathy
PL324284A1 (en) Methods of treating diabetes
AU7419096A (en) Treatment of vegetables
AU6625896A (en) Oxygen bandage
AU4979896A (en) Window treatment article
AU5268696A (en) Novel compounds and methods for therapy
AUPN271295A0 (en) Method of treatment
AU6525296A (en) Wound treatment composition
AU7236696A (en) Method of treating insulin resistance
AU5965696A (en) Terpenoid-type quinones for treatment of diabetes
AU7073096A (en) Inhibited biological degradation of oligodeoxynucleotides
AU1115095A (en) Treatment of cellulose
AU4329396A (en) Use of 3,4-diphenylchromans
AU6328696A (en) Treatment of hemoglobinopathies
AU3730093A (en) Methods of treating diabetes
AU7166896A (en) Cancer treatment
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU6829696A (en) Treatment of solutions
AU6314496A (en) Insulin
AUPN499895A0 (en) Hair treatment composition
AU7113996A (en) Methods of treating beta-amyloid-associated conditions
AU4531596A (en) Treatment of diabetic neuropathy
AU9797598A (en) Treatment of diabetic retinopathy
AU5011296A (en) Fibre treatment